tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DYN Stock Latest News

Dyne Therapeutics: Promising Advancements in Neuromuscular Treatments Drive Buy Rating
RatingsDyne Therapeutics: Promising Advancements in Neuromuscular Treatments Drive Buy Rating
13h ago
DYN
Dyne Therapeutics downgraded to Perform at Oppenheimer following additional data
PremiumThe Fly
Dyne Therapeutics downgraded to Perform at Oppenheimer following additional data
5d ago
DYN
Dyne Therapeutics downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
Dyne Therapeutics downgraded to Perform from Outperform at Oppenheimer
5d ago
DYN
Dyne announces additional one-year data from ACHIEVE study
PremiumThe Fly
Dyne announces additional one-year data from ACHIEVE study
7d ago
DYN
Dyne Therapeutics Elects Brian Posner to Board
PremiumCompany Announcements
Dyne Therapeutics Elects Brian Posner to Board
12d ago
8K
DYN
Dyne Therapeutics receives orphan drug designation in Japan for DYNE-251 in DMD
PremiumThe FlyDyne Therapeutics receives orphan drug designation in Japan for DYNE-251 in DMD
15d ago
DYN
Keurig Dr Pepper buys JDE Peet’s, Thoma Bravo to acquire Verint: Morning Buzz
Premium
The Fly
Keurig Dr Pepper buys JDE Peet’s, Thoma Bravo to acquire Verint: Morning Buzz
2M ago
S
KR
Video: RH, Wayfair slip after Trump furniture tariff probe threat
Premium
The Fly
Video: RH, Wayfair slip after Trump furniture tariff probe threat
2M ago
W
RH
Raymond James upgrades Dyne Therapeutics to Strong Buy into readout
PremiumThe Fly
Raymond James upgrades Dyne Therapeutics to Strong Buy into readout
2M ago
DYN
Dyne Therapeutics upgraded to Strong Buy from Outperform at Raymond James
PremiumThe Fly
Dyne Therapeutics upgraded to Strong Buy from Outperform at Raymond James
2M ago
DYN
Dyne Therapeutics Advances DMD Treatment with DYNE-251 Study
PremiumCompany Announcements
Dyne Therapeutics Advances DMD Treatment with DYNE-251 Study
2M ago
DYN
Dyne Therapeutics trading resumes
PremiumThe Fly
Dyne Therapeutics trading resumes
2M ago
DYN
Dyne Therapeutics trading halted, volatility trading pause
PremiumThe FlyDyne Therapeutics trading halted, volatility trading pause
2M ago
DYN
Dyne Therapeutics price target lowered to $13 from $34 at Oppenheimer
Premium
The Fly
Dyne Therapeutics price target lowered to $13 from $34 at Oppenheimer
2M ago
DYN
Dyne Therapeutics: Promising Advancements and FDA Support Drive Buy Rating
Premium
Ratings
Dyne Therapeutics: Promising Advancements and FDA Support Drive Buy Rating
2M ago
DYN
Dyne Therapeutics Gains FDA Breakthrough Designation for DYNE-251
PremiumCompany Announcements
Dyne Therapeutics Gains FDA Breakthrough Designation for DYNE-251
2M ago
8K
DYN
Dyne Therapeutics announces FDA BTD to DYNE-251
PremiumThe Fly
Dyne Therapeutics announces FDA BTD to DYNE-251
2M ago
DYN
Dyne Therapeutics: Strategic Advancements and Financial Stability Drive Buy Rating
PremiumRatings
Dyne Therapeutics: Strategic Advancements and Financial Stability Drive Buy Rating
3M ago
DYN
Dyne Therapeutics price target lowered to $31 from $37 at Raymond James
PremiumThe Fly
Dyne Therapeutics price target lowered to $31 from $37 at Raymond James
3M ago
DYN
Dyne Therapeutics price target lowered to $23 from $25 at RBC Capital
PremiumThe FlyDyne Therapeutics price target lowered to $23 from $25 at RBC Capital
3M ago
DYN
Dyne Therapeutics: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
Premium
Ratings
Dyne Therapeutics: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
3M ago
DYN
Dyne Therapeutics Advances in Neuromuscular Therapies
Premium
Company Announcements
Dyne Therapeutics Advances in Neuromuscular Therapies
3M ago
DYN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >